Lung Therapeutics
Lung Therapeutics is a therapeutics for lung injury and disease company founded in 2013 by Andrew Mazar, Steven Idell and Sreerama Shetty.
2
Funding Rounds
$50.3m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Sr****** Sh**** | - | - | - |
| St**** Id*** | - | - | - |
| An**** Ma*** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| kr***** la******** | - | - | |
| Al** A. Mu*** | - | - | - |
| Br*** Wi***** | - | - | - |
| Wi***** C. Fa**** | - | - | - |
| Aa*** Fl****** | - | - | - |
Funding series
Funding Series Analysis
The company Lung Therapeutics has raised a total of $36m in funding over 2 rounds.
Key Insights:
- Lung Therapeutics Series C round, June 2019: $36m
- Lung Therapeutics Inc funding round, June 2017: $14.3m
Lung Therapeutics Series C round, June 2019
$36m
Lung Therapeutics Inc funding round, June 2017
$14.3m
Industries
Lung Therapeutics is active in the following industries: